Active, Not Recruiting
Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)
NCT06087835
- Conditions
- Chronic Kidney Disease With High Proteinuria, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +4 more
- Locations
-
- Research Site Huntsville, Alabama, United States
- Research Site Sun City West, Arizona, United States
- Research Site Bakersfield, California, United States
- Research Site Huntington Park, California, United States